josh baldwin
biotech communications and marketing; new yorker; ny sports fan; pepperdine alum
@jaredwhitlock.bsky.social
features editor @endpts.com / fall 2021 fellow @ksjatmit.bsky.social Writing (and editing) stories on rare disease medicine, diagnostics and China Reach out privately on Signal: jaredwhitlock.73
@shelbylivingston.bsky.social
Reporter covering health tech for Endpoints News. Formerly Business Insider and Modern Healthcare. Charleston native, Clemson alum. Go Tigers!
@nicolewetsman.bsky.social
deputy editor @endpts.com // formerly the verge & abc news // soccer posts
@leileiwu.bsky.social
reporting on drugs and biotechs @endpoints • email me: [email protected] • Signal: leileiwu.24 • ✌️
@ash.hematology.org
The American Society of Hematology (ASH) is the world's largest professional society concerned with the causes and treatments of blood disorders. #Hematology #MedSky #BloodSky #HemeSky #HemeOnc 🩸 hematology.org
@bristolmyerssquibb.bsky.social
@bms-news.bsky.social
@bms-us.bsky.social
@novartis.bsky.social
@carolynbertozzi.bskyverified.social
Baker Family Director, Sarafan ChEM-H, Stanford University and HHMI; EIC of ACS Cent Sci; All views and opinions expressed are my own.
@applehelix.bsky.social
Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by Vinay Prasad. http://linkedin.com/in/jliang1/
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@lisamjarvis.bsky.social
Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. [email protected] and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@biotechhangout.bsky.social
@simonbayly.bsky.social
Reformed chemist 👨🔬 IP licensing and spinouts at the Francis Crick Institute. Also post about cycling 🚲 Opinion my own etc.
@peterkolchinsky.bsky.social
Biotech investor. Virologist. Author: The Great American Drug Deal. Founder: No Patient Left Behind. Healthcare reform advocate. Daughter says I’m cool 75% of the time; son says 100%.
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
@kylelahucik.bsky.social
reporting on the $, people & startups in the biotech world for Endpoints News | [email protected] | also coach high school XC + Track & Field team | askin Qs, joggin 26.2 | 🌎🏳️🌈🏃🏻♂️🗞️💨
@andrewedunn.bsky.social
Reporter @ Endpoints News Covering biotech, pharma, AI, and more — the future of medicine [email protected]
@gwendolynawu.bsky.social
Covering biotech startups and VCs at BioPharma Dive. Hobbyist baker and dog wrangler.
@pearlf.bsky.social
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
@susannalharris.bsky.social
Helping scientists communicate. Working in biotech VC, living in San Francisco, reading in every available armchair.
@maxbayer.bsky.social
Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | [email protected] or chat me for Signal. he/him
@maxgelman.bsky.social
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum.
@jonathanwosen.bsky.social
West Coast Biotech & Life Sciences Reporter for Stat News. Stanford Immunology PhD & UCSC SciCom alum. Tips? [email protected]. Signal: jwosen.27
@natbiotech.nature.com
Publishing the best of biotech science and business. Part of @natureportfolio.bsky.social. Find us on Twitter, Facebook & Instagram.
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
@gracecolon.bsky.social
Boards @MIT @VoyagerTx @IAmBiotech @BloomScience Emm; former CEO InCarda; alum @MITChemE @Penn; #BLM #LatinX🇵🇷🌈🌊💙 Longtime biotech geek, board member and entrepreneur. #BioSky #BiotechCEOSisterhood
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@daphnezohar.bsky.social
Founder & CEO of www.SeaportTx.com developing new medicines for neuropsychiatric disorders. Co-founder Karuna Tx (KarXt/Cobenfy now at BMS). Founding CEO & Senior Advisor www.puretechhealth.com. Co founder/host @BiotechCH. Board of BIO #Biotech #BioSky
@gilman.bsky.social
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant, #BioSky. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky Priors: Bloomberg News + the Covid vaccine tracker. CQ.
@anjkhem.bsky.social
Senior Health Reporter, Yahoo Finance [email protected] | DM for Signal #biosky #medsky #publichealth #idsky #pharmasky #news #skyrx #econsky